{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:28Z","timestamp":1790916808453,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":147,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015308","name":"Xinjiang Uygur Autonomous Region Department of Science and Technology","doi-asserted-by":"publisher","award":["2026E02065"],"award-info":[{"award-number":["2026E02065"]}],"id":[{"id":"10.13039\/501100015308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009110","name":"Xinjiang Uygur Autonomous Region Natural Science Foundation","doi-asserted-by":"publisher","award":["2023D01D14"],"award-info":[{"award-number":["2023D01D14"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009110","name":"Xinjiang Uygur Autonomous Region Natural Science Foundation","doi-asserted-by":"publisher","award":["2025D01C175"],"award-info":[{"award-number":["2025D01C175"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101269","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:04:03Z","timestamp":1780070643000},"page":"101269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical significance of immunocyte- and ferroptosis-related markers for the prognosis of patients with tenosynovial giant cell tumor: A cross-sectional study"],"prefix":"10.1016","volume":"48","author":[{"given":"Zhi-qiang","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesitai","family":"Saierhali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1443-4769","authenticated-orcid":false,"given":"Chen\u2011xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-1500","authenticated-orcid":false,"given":"Zhong\u2011cheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101269_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102491","article-title":"Best clinical management of tenosynovial giant cell tumour (TGCT): a consensus paper from the community of experts","volume":"112","author":"Stacchiotti","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ctarc.2026.101269_bib0002","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1302\/0301-620X.103B4.BJJ-2020-1582.R1","article-title":"Management of tenosynovial giant cell tumour of the foot and ankle","volume":"4","author":"Spierenburg","year":"2021","journal-title":"Bone Joint J. 103-B"},{"key":"10.1016\/j.ctarc.2026.101269_bib0003","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2022.06.028","article-title":"Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours: long-term follow-up of nilotinib in TGCT","volume":"173","author":"Spierenburg","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101269_bib0004","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1186\/s13018-023-04279-2","article-title":"Identification of potential diagnostic biomarkers for tenosynovial giant cell tumour by integrating microarray and single-cell RNA sequencing data","volume":"18","author":"Chen","year":"2023","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.ctarc.2026.101269_bib0005","first-page":"71","article-title":"A preliminary study concerning comorbidity mechanism and potential therapeutic targets in PVNS and RA of temporomandibular joint","volume":"23","author":"Li","year":"2025","journal-title":"Chin. J. Bioinform."},{"key":"10.1016\/j.ctarc.2026.101269_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.820046","article-title":"Update on tenosynovial giant cell tumor, an inflammatory arthritis with neoplastic features","volume":"13","author":"Robert","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101269_bib0007","doi-asserted-by":"crossref","first-page":"421","DOI":"10.14336\/AD.2023.0509","article-title":"Identification of Cathepsin B as a therapeutic target for ferroptosis of macrophage after spinal cord injury","volume":"15","author":"Xu","year":"2023","journal-title":"Aging Dis."},{"key":"10.1016\/j.ctarc.2026.101269_bib0008","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ctarc.2026.101269_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210021","article-title":"ACSL4-mediated ferroptosis and its potential role in central nervous system diseases and injuries","volume":"24","author":"Jia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101269_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156330","article-title":"Effect of Ferrostatin-1 on temporomandibular joint synovitis induced by abnormal flow fluid shear stress: an in vitro study","volume":"278","author":"Yu","year":"2026","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ctarc.2026.101269_bib0011","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/14796694.2024.2396227","article-title":"MANEUVER: a Phase III study of pimicotinib to assess efficacy and safety in tenosynovial giant cell tumor patients","volume":"22","author":"Niu","year":"2026","journal-title":"Fut. Oncol."},{"key":"10.1016\/j.ctarc.2026.101269_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.102904","article-title":"Therapeutic advances in Tenosynovial giant cell tumor: targeting the CSF1\/CSF1R axis","volume":"134","author":"Assi","year":"2025","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ctarc.2026.101269_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.868639","article-title":"Ferroptosis-mediated formation of tumor-promoting immune microenvironment","volume":"12","author":"Bi","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101269_bib0014","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12943-024-02130-8","article-title":"Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ctarc.2026.101269_bib0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ctarc.2026.101269_bib0016","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1186\/s12885-023-11587-7","article-title":"Clinical retrospective analysis with a predictive model for diffused-tenosynovial giant cell tumors of the temporomandibular joint","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctarc.2026.101269_bib0017","article-title":"Expression of MIF, Beclin1, and LC3 in human salivary gland adenoid cystic carcinoma and its prognostic value","volume":"98","author":"Li","year":"2019","journal-title":"Medicine(Baltimore)"},{"key":"10.1016\/j.ctarc.2026.101269_bib0018","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3899\/jrheum.160816","article-title":"Tenosynovial giant cell tumor: incidence, prevalence, patient characteristics, and recurrence. A registry-based cohort study in Denmark","volume":"44","author":"Ehrenstein","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ctarc.2026.101269_bib0019","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/rheumatology\/keu230","article-title":"Long-term follow-up results of primary and recurrent pigmented villonodular synovitis","volume":"53","author":"Verspoor","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ctarc.2026.101269_bib0020","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1097\/SCS.0000000000006564","article-title":"Tenosynovial giant cell tumor in an infant","volume":"31","author":"Shahriari","year":"2020","journal-title":"J. Craniofac. Surg."},{"key":"10.1016\/j.ctarc.2026.101269_bib0021","first-page":"239","article-title":"Predictive study regarding potential diagnostic markers in primary pigmented villonodular synovitis of temporomandibular joint","volume":"14","author":"Li","year":"2023","journal-title":"Oral Biomed."},{"key":"10.1016\/j.ctarc.2026.101269_bib0022","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.ctarc.2026.101269_bib0023","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.tem.2021.04.010","article-title":"Ferritinophagy and ferroptosis in the management of metabolic diseases","volume":"32","author":"Ajoolabady","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ctarc.2026.101269_bib0024","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00018-020-03679-5","article-title":"New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis","volume":"78","author":"Castillo","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.ctarc.2026.101269_bib0025","doi-asserted-by":"crossref","first-page":"44849","DOI":"10.18632\/oncotarget.6438","article-title":"ACSL4 promotes prostate cancer growth, invasion and hormonal resistance","volume":"6","author":"Wu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctarc.2026.101269_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103847","article-title":"Contribution of ferroptosis and GPX4\u2032s dual functions to osteoarthritis progression","volume":"76","author":"Miao","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ctarc.2026.101269_bib0027","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3390\/biomedicines9111679","article-title":"Ferroptosis as a major factor and therapeutic target for neuroinflammation in Parkinson's disease","volume":"9","author":"Ko","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ctarc.2026.101269_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27329","article-title":"Tumor-infiltrating CD8+ sub-populations in primary and recurrent glioblastoma: an in-silico study","volume":"10","author":"Abdoli Shadbad","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ctarc.2026.101269_bib0029","article-title":"Chemoradiotherapy-induced ACKR2+ tumor cells drive CD8+ T cell senescence and cervical cancer recurrence","volume":"5","author":"Dai","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ctarc.2026.101269_bib0030","article-title":"Osteoclast-derived apoptotic bodies inhibit naive CD8+ T cell activation via Siglec15, promoting breast cancer secondary metastasis","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ctarc.2026.101269_bib0031","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.clinre.2015.09.005","article-title":"Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer","volume":"40","author":"Park","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.ctarc.2026.101269_bib0032","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00432-018-2646-0","article-title":"Tumor cell expression of CD163 is associated to postoperative radiotherapy and poor prognosis in patients with breast cancer treated with breast-conserving surgery","volume":"144","author":"Garvin","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101269_bib0033","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12307-014-0145-7","article-title":"Macrophage infiltration in tumor stroma is related to tumor cell expression of CD163 in colorectal cancer","volume":"7","author":"Shabo","year":"2014","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.ctarc.2026.101269_bib0034","article-title":"CSF1-CSF1R signaling mediates tumor cell-macrophage crosstalk and prognosis in ccRCC","author":"Li","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ctarc.2026.101269_bib0035","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ijom.2019.10.022","article-title":"Clinical and immunohistochemical analysis of diffuse tenosynovial giant cell tumour of the temporomandibular joint","volume":"49","author":"Wang","year":"2020","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.ctarc.2026.101269_bib0036","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/PAS.0b013e318158428f","article-title":"Malignant diffuse-type tenosynovial giant cell tumors: a series of 7 cases comparing with 24 benign lesions with review of the literature","volume":"32","author":"Li","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ctarc.2026.101269_bib0037","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.62347\/GLJC3405","article-title":"Prediction of pediatric Wilms tumor recurrence using interpretable machine learning models: insights from a 20-year real-world study and the prognostic value of Ki-67","volume":"15","author":"Fang","year":"2025","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101269_bib0038","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1016\/j.clbc.2025.04.001","article-title":"High Ki-67 expression is associated with increased risk of distant recurrence in Oncotype Dx low risk breast cancer","volume":"25","author":"Labidi","year":"2025","journal-title":"Clin. Breast Cancer"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:58:01Z","timestamp":1790913481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226001802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":38,"alternative-id":["S2468294226001802"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101269","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of immunocyte- and ferroptosis-related markers for the prognosis of patients with tenosynovial giant cell tumor: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101269"}}